Interventional neuroradiology (INR), also known as neuro-interventional surgery (NIS), is a medical subspecialty of neurosurgery, neurology, and radiology, which focuses on minimally invasive image-based technologies and processes. It is used for diagnosis and treatment of diseases related to spine, head, and neck. The products included in neurointerventional devices consist of clips, stents, and coils. These are utilized for treating of various neurovascular disorders such as cerebral artery stenosis, brain aneurysms, brain arteriovenous malformation (AVM), carotid-cavernous fistula (CCF), dural arteriovenous fistula (dAVFs), and extracranial (brachiocephalic) atherosclerosis. Minimally invasive procedures are used for variety of treatments such as stroke treatment by delivering clot-busting drugs directly to the site of the blockage, spinal treatments by injecting bone cement into a fractured vertebra in order to reinforce the bone, and aneurysm therapy by inserting platinum coils into the aneurysm bulge to prevent clotting and rupture.
Market Dynamics
Market players are focusing on new product launches, which is expected to propel the global neuro-interventional devices market growth during the forecast period. For instance, in ecember 2019, Imperative Care, Inc., a biotechnology company completed the initial closing of a Series C financing of US$ 85 million to support the commercial launch of the company’s portfolio that includes the latest advancement in neurovascular devices used for the treatment of ischemic and hemorrhagic strokes. The company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for access catheters which helps in smooth and consistent navigation into blood vessels of the brain. The company also received U.S. FDA clearance for its ZOOM Aspiration System, designed to simplify clot removal during ischemic stroke.
Key features of the study:
- This report provides an in-depth analysis of the global neuro-interventional devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neuro-interventional devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Penumbra, Inc., Stryker Corporation, Medtronic PLC., Johnson & Johnson Services, Inc., Terumo Corporation, Insera Therapeutics Inc., Anaconda Biomed S.L., and Perflow Medical Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neuro-interventional devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global neuro-interventional devices market
Detailed Segmentation:
- Global Neuro-interventional Devices Market, By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- Global Neuro-interventional Devices Market, By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- Global Neuro-interventional Devices Market, By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Global Neuro-interventional Devices Market, By Region:
- North America
- By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Country
- Latin America
- By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Embolization Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Flow Disruption
- Flow Diverters
- Intrasaccular Devices
- Liquid Embolic Coils
- Balloons
- Stent Retrievers
- By Technique
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
-
- Penumbra, Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Stryker Corporation
- Medtronic PLC.
- Johnson & Johnson Services, Inc.
- Terumo Corporation
- Insera Therapeutics Inc.
- Anaconda Biomed S.L.
- Perflow Medical Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
